Aldeyra Therapeutics Announces 2018 Research Day
Aldeyra Therapeutics Announces 2018 Research Day |
[20-June-2018] |
LEXINGTON, Mass., June 20, 2018 /PRNewswire/ -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company devoted to development of next-generation medicines to improve the lives of patients with immune-mediated diseases, today announced that it will host a Research Day to provide an update on current early-stage research programs. The day will include presentations from members of the management team focusing on development plans for novel product candidates in systemic inflammatory disease, retinal disease, and cancer. Management presentations will begin at 9:00 a.m. Eastern Time on Tuesday, June 26, 2018, at the offices of Dechert, LLP in New York City. A live webcast of the presentation and slide deck will be available via the Company's Investor Relations website at http://ir.aldeyra.com. Following the live webcast, an archived version will be available on the website until June 25, 2019. About Aldeyra Therapeutics Corporate Contact: Investor Contact: Media Contact:
SOURCE Aldeyra Therapeutics, Inc. | ||
Company Codes: NASDAQ-SMALL:ALDX |
© 2018 PR Newswire. All Rights Reserved.
#content-news .main-news{color:#737373;font-size:14px;line-height:inherit;text-align:inherit}